# Vicore Pharma Holding AB (VCRE)

Source: https://www.quantisnow.com/company/VCRE
Generated: 2026-11-08T01:15:03.065Z

- Ticker: VCRE
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- SEC CIK: 0002124403
- Website: https://vicorepharma.com/

## About

Vicore Pharma is a clinical-stage biopharmaceutical company unlocking the potential of a new class of drugs with disease-modifying potential in respiratory and fibrotic diseases, including idiopathic pulmonary fibrosis (IPF). The company's lead program, buloxibutid, is an oral small-molecule angiotensin II type 2 receptor agonist, which received Orphan Drug and Fast Track designations from the United States Food and Drug Administration and is currently being investigated in the global 52-week Phase 2b ASPIRE trial in IPF. Vicore Pharma is publicly listed on Nasdaq Stockholm (VICO) and Nasdaq US (VCRE). www.vicorepharma.

## Latest VCRE news and filings

- 2026-11-05 22:15 UTC [SEC Form 6-K] [SEC Form 6-K filed by Vicore Pharma Holding AB](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-vicore-pharma-holding-ab-6777370)
- 2026-11-03 22:15 UTC [SEC Form 6-K] [SEC Form 6-K filed by Vicore Pharma Holding AB](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-vicore-pharma-holding-ab-6770496)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/VCRE
- Earnings history: https://www.quantisnow.com/earnings/VCRE
- Dividend history: https://www.quantisnow.com/dividends/VCRE
- Insider transactions: https://www.quantisnow.com/insiders/VCRE
- Options chain: https://www.quantisnow.com/options/VCRE
- SEC 8-K filings only: https://www.quantisnow.com/company/VCRE/8-k
- RSS and alerts for VCRE: https://www.quantisnow.com/docs/rss-feeds.md